Advertisement

Topics

Capricor's IND for Duchenne muscular dystrophy therapy approved by FDA

04:52 EST 1 Dec 2017 | SmartBrief

Capricor Therapeutics' investigational new drug application for CAP-1002 was approved by the FDA.  -More

Original Article: Capricor's IND for Duchenne muscular dystrophy therapy approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Capricor's IND for Duchenne muscular dystrophy therapy approved by FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...